2025-524106-14-00已完成1 期
A study in healthy people to test how vicadrostat affects the heart
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 45
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
CT Disclosure & Data Transparency
Scientific
Boehringer Ingelheim International GmbH
研究点 (2)
Loading locations...
相似试验
招募中
2 期
Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)Heart FailureNCT07304817University Medical Center Groningen100
招募中
3 期
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure.2023-509706-30-00Boehringer Ingelheim International GmbH2,461
招募中
3 期
A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure, and cardiovascular diseasehypertensioncardiovascular disease2025-521188-11-00Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.4,386
尚未招募
3 期
Vrishadi lepa for the treatment of tinea/dermatomycosisCTRI/2024/08/073128DrMoumita Tewari30
招募中
1 期
A study in healthy men to compare the amount of vicadrostat and empagliflozin in the blood when taken separately and together2024-518103-21-00Boehringer Ingelheim International GmbH15